FDA Authorizes Pfizer-BioNTech Vaccine for Children 12 to 15
The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.
Source: NYT Health - Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Clinical Trials Pediatric Inflammatory Multisystem Syndrome (PIMS) Coronavirus Risks and Safety Concerns Vaccination and Immunization Children and Childhood Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) BioNTech SE Pf Source Type: news
More News: Children | Clinical Trials | Coronavirus | COVID-19 | Health | Pediatrics | Pfizer | Science | Vaccines